Maineville, OH, United States of America

Michael Philip Clark

USPTO Granted Patents = 18 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 111(Granted Patents)


Location History:

  • Loveland, OH (US) (2003 - 2008)
  • Maineville, OH (US) (2007 - 2009)

Company Filing History:


Years Active: 2003-2009

Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovations of Michael Philip Clark

Introduction

Michael Philip Clark is a notable inventor based in Maineville, Ohio. He has made significant contributions to the field of cytokine inhibitors, holding a total of 18 patents. His work focuses on developing innovative solutions to combat inflammatory diseases in humans and higher mammals.

Latest Patents

Among his latest patents are two groundbreaking inventions. The first is related to bicyclic pyrazolone cytokine inhibitors, specifically 6,7-dihydro-5H-pyrazolo[1,2α]pyrazol-1-ones. This invention aims to inhibit the extracellular release of inflammatory cytokines, which are responsible for various disease states. The second patent involves tri-substituted ureas as cytokine inhibitors, which also target the extracellular release of inflammatory cytokines. Both inventions include compositions and methods for controlling the enzymes that contribute to these disease states.

Career Highlights

Michael Philip Clark is currently associated with The Procter & Gamble Company, where he continues to innovate and develop new solutions in the field of health and wellness. His extensive experience and dedication to research have positioned him as a key figure in his area of expertise.

Collaborations

Michael has collaborated with notable colleagues such as Biswanath De and Matthew John Laufersweiler. Their combined efforts have contributed to the advancement of research in cytokine inhibitors.

Conclusion

Michael Philip Clark's innovative work in the field of cytokine inhibitors showcases his commitment to improving health outcomes. His patents reflect a deep understanding of the mechanisms behind inflammatory diseases and offer promising solutions for future treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…